March 25, 2017 9:50 PM ET

Healthcare Equipment and Supplies

Company Overview of J-Pac, LLC

Company Overview

J-Pac, LLC provides contract manufacturing, packaging outsourcing, and customized services for medical devices and diagnostic products. The company manufactures anatomically correct, class III implantable textile assemblies; lab-on-chip reagent blisters; complex thermoformed packaging; and turnkey packaging. It manufactures medical devices including surgical instruments, endoscopic retrieval bags, devices with pre-tied surgical knots, point-of-use mixing devices, cannula, laparoscopic ports, endoscopic components, robotic assisted surgery instruments, sheaths, containment vessels for bone cement, and delivery systems. The company develops disposable packaging such as flexible form/fill/seal,...

25 Centre Road

Somersworth, NH 03878-2927

United States

Founded in 1983





Key Executives for J-Pac, LLC

Chief Executive Officer and President
Age: 53
Chief Financial Officer
Vice President of Operations
Vice President of Innovation Services Group
Compensation as of Fiscal Year 2016.

J-Pac, LLC Key Developments

J-Pac Medical Announces New Allograft Processing Products for Tissue Banks

J-Pac Medical announced new custom fabricated mesh bags and filters for tissue bank allograft processing. J-Pac's custom shaped and assembled medical-quality textile components can be tailored to specific allograft processing needs and combined with other sterile devices in a single kit for quality improvement, processing efficiency and cost savings. The company's well-crafted fabricated mesh bags and filters are manufactured and sterilized to the utmost quality standards for customers to decontaminate and prepare allograft products for implantation. Components are made with medical quality textiles, and incorporate easy closing and opening mechanisms that preclude the need for particulate generating cutting and fashioning that is common within these processes. Custom shaped and assembled components are terminally sterilized and are provided in ready-to use formats and packaging. By combining several medical apparatuses into a single sterile component kit, J-Pac enables faster preparation of allografts for medical and surgical applications and is able to meet unique tissue bank allograft processing needs.

J-Pac Medical Introduces New High-Volume Automated Manufacturing Capabilities for On-Chip Reagent Blisters

J-Pac Medical announced that it will now offer new high-volume automated manufacturing capabilities specifically designed for the company's on-chip reagent blister technology. J-Pac Medical's full spectrum of automated production capabilities is designed for customers experiencing rapid growth in the commercialization of new microfluidic-based diagnostics -- from prototyping, pilot production, clinical trials, product launch and full commercialization. As the market leader for reagent blisters, J-Pac can now manufacture tens of millions reagent blisters to support customers from concept through global commercialization. J-Pac Medical's unique high-volume, automated production capabilities have been developed to incorporate the precision for unit dose reagent blisters. This includes: Precision reagent filling for single and multiple-well formats with in-line quality control; Self-diagnostics with automated detection of non-conforming materials; Multiple sealing profiles unique to each customer application. Microfluidic diagnostic platforms utilizing J-Pac Medical's on-chip reagent blisters help eliminate multi-step lab processes where human error and instrument contamination are most likely to occur. J-Pac has developed two reagent delivery technologies in single or multi-well formats for common lab-on-chip formats: burst and frangible seal blisters. Frangible and burst seal technology reduces test complexity by storing and enabling the controlled release of testing reagents, eliminating the need for complex fluid handling. As a result, the device manufacturer is able to better control performance variability, reduce overall manufacturing and disposal costs, and simplify the end-user experience.

Phil Littlefield Joins J-Pac Medical as Vice President of Operations

J-Pac Medical reported that Phil Littlefield has joined the company as Vice President of Operations. Littlefield has proven to be a performance-driven operations leader with demonstrated success delivering superior results in Lean/Six Sigma manufacturing, global supply chain and logistics management, and organizational development. In his role at J-Pac, Littlefield will utilize his diverse manufacturing and supply chain expertise to leverage J-Pac's capabilities and emphasize continuous improvement and best-in-class operating systems to strengthen J-Pac's presence across the medical device industry.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact J-Pac, LLC, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at